Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Infectious Diseases

• Publication date

  2014-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/cid/cit735PMID 24218102PMCID PMC3890340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic Lyme disease.

  2015cited by this paper
• Orchestration of inflammation and adaptive immunity in Borrelia burgdorferi-induced arthritis by neutrophil-activating protein A.

  2013cited by this paper
• Quantitative Detection of Borrelia burgdorferi sensu lato in Erythema Migrans Skin Lesions Using Internally Controlled Duplex Real Time PCR

  2013cited by this paper
• A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease.

  2013influential reference
• Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.

  2012cited by this paper
• Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy.

  2012cited by this paper
• Hamster and Murine Models of Severe Destructive Lyme Arthritis

  2012cited by this paper
• Treating Human Autoimmunity: Current Practice and Future Prospects

  2012cited by this paper
• Treatment of erythema migrans with doxycycline for 10 days versus 15 days.

  2012influential reference
• Targeting IL-17 and TH17 cells in chronic inflammation

  2012cited by this paper
• Response to self antigen imprints regulatory memory in tissues

  2011cited by this paper
• Role of Interleukin-23 (IL-23) Receptor Signaling for IL-17 Responses in Human Lyme Disease

  2011cited by this paper
• Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis.

  2011cited by this paper
• Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms.

  2010cited by this paper
• Subjective symptoms after treatment of early Lyme disease.

  2010influential reference
• Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-responsive Lyme arthritis.

  2010cited by this paper
• Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis.

  2008cited by this paper
• Orchestrating the orchestrators: chemokines in control of T cell traffic

  2008cited by this paper
• Higher mRNA levels of chemokines and cytokines associated with macrophage activation in erythema migrans skin lesions in patients from the United States than in patients from Austria with Lyme borreliosis.

  2008cited by this paper
• Interleukin-23 Is Required for Development of Arthritis in Mice Vaccinated and Challenged with Borrelia Species

  2008cited by this paper
• A critical appraisal of "chronic Lyme disease".

  2007cited by this paper
• Interleukin-17 family members and inflammation.

  2004cited by this paper
• The emergence of Lyme disease.

  2004cited by this paper
• Study and treatment of post Lyme disease (STOP-LD)

  2003cited by this paper
• Inhibition of Interleukin-17 Prevents the Development of Arthritis in Vaccinated Mice Challenged with Borrelia burgdorferi

  2003cited by this paper
• A CRITICAL APPRAISAL

  2002cited by this paper
• Lyme disease.

  2001cited by this paper
• Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.

  2001cited by this paper
• Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.

  1992cited by this paper
• Lyme Disease Associated with Fibromyalgia

  1992cited by this paper
• The T-cell proliferative assay in the diagnosis of Lyme disease.

  1991cited by this paper
• Summary of the first 100 patients seen at a Lyme disease referral center.

  1990cited by this paper

• Lower Frequency of Multiple Erythema Migrans Skin Lesions in Lyme Reinfections, Europe

  2025cites this paper
• Toll-like receptor 1 polymorphism is associated with impaired immune tolerance, dysregulated inflammatory responses to Borrelia burgdorferi, and heightened risk of post-infectious Lyme arthritis

  2025cites this paper
• Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society

  2025cites this paper
• Aberrant T-cell phenotypes in a cohort of patients with post-treatment Lyme disease

  2025cites this paper
• Key inflammatory mediators drive the resolution of acute Lyme disease

  2025cites this paper
• The peptidoglycan of Borrelia burgdorferi can persist in discrete tissues and cause systemic responses consistent with chronic illness.

  2025cites this paper
• A comprehensive genetic map of cytokine responses in Lyme borreliosis

  2024cites this paper
• Symptoms after Lyme disease: What's past is prologue.

  2024cites this paper
• Current and emerging approaches for eliminating Borrelia burgdorferi and alleviating persistent Lyme disease symptoms

  2024influential citation
• Variants in the Late Cornified Envelope Gene Locus Are Associated With Elevated T-helper 17 Responses in Patients With Postinfectious Lyme Arthritis.

  2024cites this paper
• Persistent Symptoms After Lyme Disease: Clinical Characteristics, Predictors, and Classification.

  2024cites this paper
• Cytokine levels in patients with multiple sclerosis and chronic neuroborreliosis

  2024cites this paper
• Suppression of host humoral immunity by Borrelia burgdorferi varies over the course of infection

  2024cites this paper
• Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood

  2023cites this paper
• Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study

  2023cites this paper
• Neuropsychiatric Lyme Disease and Vagus Nerve Stimulation

  2023cites this paper
• Posttreatment Lyme disease syndrome and myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and comparison of pathogenesis

  2023influential citation
• The Interaction of Borrelia burgdorferi with Human Dendritic Cells: Functional Implications.

  2023cites this paper
• Acceptance of diagnosis and management satisfaction of patients with “suspected Lyme borreliosis” after 12 months in a multidisciplinary reference center: a prospective cohort study

  2023cites this paper
• Lyme disease and the pursuit of a clinical cure

  2023cites this paper
• Inflammation, biofilms and dietary measures in post treatment Lyme disease syndrome

  2022cites this paper
• Neuropsychiatric Symptoms and Tick-Borne Diseases.

  2022cites this paper
• Persistent Symptoms After Treatment of Lyme Disease.

  2022cites this paper
• Identifying platelet-derived factors as amplifiers of B. burgdorferi-induced cytokine production

  2022cites this paper
• Six versus 2 weeks treatment with doxycycline in European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blinded, randomised and placebo-controlled trial

  2022cites this paper
• Innate and Th1/Th17 adaptive immunity in acute and convalescent Brazilian borreliosis disease

  2021cites this paper
• The main postinfectious syndromes

  2021cites this paper
• Persistent Anti-Borrelia IgM Antibodies without Lyme Borreliosis in the Clinical and Immunological Context

  2021cites this paper
• A Review of Post-treatment Lyme Disease Syndrome and Chronic Lyme Disease for the Practicing Immunologist

  2021cites this paper
• Nonspecific symptoms following infection with Borrelia burgdorferi sensu lato: A retrospective cohort study.

  2021cites this paper
• A selective antibiotic for Lyme disease.

  2021cites this paper
• Recent Progress in Lyme Disease and Remaining Challenges

  2021influential citation
• LB17. Immunosequencing of the T-Cell Receptor Repertoire Reveals Signatures Specific for Diagnosis and Characterization of Early Lyme Disease

  2021cites this paper
• Lyme Borreliosis and Associations With Mental Disorders and Suicidal Behavior: A Nationwide Danish Cohort Study.

  2021cites this paper
• Evaluation of selected variables to determine if any had predictive value for, or correlated with, residual symptoms at approximately 12 months after diagnosis and treatment of early Lyme disease.

  2021cites this paper
• Posttreatment Lyme disease syndromes: distinct pathogenesis caused by maladaptive host responses.

  2020cites this paper
• Cytokine Milieu in Infectious Disease: A Sword or a Boon?

  2020cites this paper
• Characterization of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidases from Borrelia burgdorferi: Antibiotic targets for Lyme disease.

  2020cites this paper
• Posttreatment Symptoms in Lyme Borreliosis.

  2020cites this paper
• Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease

  2020cites this paper
• Anti-lysoganglioside and other anti-neuronal autoantibodies in post-treatment Lyme Disease and Erythema Migrans after repeat infection

  2020cites this paper
• Nonspecific Symptoms in Children Referred to a Lyme Borreliosis Center

  2020cites this paper
• Lyme borreliosis: diagnosis and management

  2020cites this paper
• Course and Outcome of Erythema Migrans in Pregnant Women

  2020cites this paper
• Borrelia burgdorferi-Induced Changes in the Class II Self-Immunopeptidome Displayed on HLA-DR Molecules Expressed by Dendritic Cells

  2020cites this paper
• Metabolic Response in Patients with Post-Treatment Lyme Disease Symptoms/Syndrome.

  2020cites this paper
• A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients

  2020cites this paper
• Lyme Disease in Humans.

  2020influential citation
• Systemic immune responses in patients with early localized or early disseminated Borrelia afzelii lyme borreliosis

  2020cites this paper
• LYME DISEASE AND RELAPSING FEVER SPIROCHETES

  2020cites this paper
• MAPPING THE LYME DISEASE CONTROVERSY

  2020cites this paper
• DIAGNOSING AND TREATING LYME

  2020cites this paper
• 5. Lyme Disease, Evidence-Based Medicine, and the Biopolitics of Truthmaking

  2020cites this paper
• References

  2020cites this paper
• Notes

  2020cites this paper
• LIVING LYME

  2020cites this paper
• Lyme Disease Outside In

  2020cites this paper
• PREVENTING LYME

  2020cites this paper
• Through Lyme’s Looking Glass

  2020cites this paper
• A Multivariate Negative-Binomial Model with Random Effects for Differential Gene-Expression Analysis of Correlated mRNA Sequencing Data

  2019cites this paper
• Borrelial serology does not contribute to the diagnostic work-up of patients with nonspecific symptoms.

  2019cites this paper
• Inflammatory Immune Responses in Patients with Tick-Borne Encephalitis: Dynamics and Association with the Outcome of the Disease

  2019cites this paper
• Estimation of cumulative number of post-treatment Lyme disease cases in the US, 2016 and 2020

  2019cites this paper
• Persistent symptoms attributed to Lyme disease and their antibiotic treatment. Results from the PLEASE study

  2019cites this paper
• Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect)

  2019cites this paper
• Pediatric Antibiotic-refractory Lyme Arthritis: A Multicenter Case-control Study

  2019cites this paper
• C-Reactive Protein Response in Patients With Post-Treatment Lyme Disease Symptoms Versus Those With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  2018cites this paper
• Clinical Course, Serologic Response, and Long-Term Outcome in Elderly Patients with Early Lyme Borreliosis

  2018cites this paper
• Place de la médecine intégrative dans la prise en charge thérapeutique des maladies vectorielles à tiques

  2018cites this paper
• Identifying Vancomycin as an Effective Antibiotic for Killing Borrelia burgdorferi

  2018cites this paper
• Robust B Cell Responses Predict Rapid Resolution of Lyme Disease

  2018cites this paper
• Induction of Interleukin 10 by Borrelia burgdorferi Is Regulated by the Action of CD14-Dependent p38 Mitogen-Activated Protein Kinase and cAMP-Mediated Chromatin Remodeling

  2018cites this paper
• Neuroimmunomodulators in Neuroborreliosis and Lyme Encephalopathy

  2018cites this paper
• 46 – Lyme Disease

  2017cites this paper
• Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society

  2017cites this paper
• T-Helper 17 Cell Cytokine Responses in Lyme Disease Correlate With Borrelia burgdorferi Antibodies During Early Infection and With Autoantibodies Late in the Illness in Patients With Antibiotic-Refractory Lyme Arthritis

  2017cites this paper
• When a patient suspected with juvenile idiopathic arthritis turns out to be diagnosed with an infectious disease – a review of Lyme arthritis in children

  2017cites this paper
• The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome

  2017cites this paper
• OF THERAPY FOR ACUTE LYME DISEASE IDENTIFIES PATIENTSAT RISK FOR DEVELOPMENT OF POST TREATMENT LYME DISEASE SYNDROME WHO WILL BENEFIT FROM FURTHER ANTIBOTC THERAPY

  2017cites this paper
• Early Disseminated Lyme Disease with Carditis Complicated by Posttreatment Lyme Disease Syndrome

  2017cites this paper
• Interferon-γ-induced protein 10 in Lyme disease.

  2017cites this paper
• Synthesis of Th17 cytokines in the culture of peripheral blood mononuclear cells stimulated with Borrelia burgdorferi sensu lato.

  2016cites this paper
• Differences in Genotype, Clinical Features, and Inflammatory Potential of Borrelia burgdorferi sensu stricto Strains from Europe and the United States

  2016cites this paper
• CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study

  2016cites this paper
• Effects of the Lyme disease pathogen Borrelia burgdorferi on murine bone biology

  2016cites this paper
• Autophagy suppresses host adaptive immune responses toward Borrelia burgdorferi

  2016cites this paper
• Longitudinal Transcriptome Analysis Reveals a Sustained Differential Gene Expression Signature in Patients Treated for Acute Lyme Disease

  2016influential citation
• CD4+ cell-derived interleukin-17 in a model of dysregulated, Borrelia-induced arthritis.

  2016cites this paper
• Lyme borreliosis

  2016cites this paper
• Regulatory Mechanisms in Borrelia Burgdorferi-Induced Arthritis

  2016influential citation
• Update of the Swiss guidelines on post-treatment Lyme disease syndrome.

  2016cites this paper
• Lyme disease: a rigorous review of diagnostic criteria and treatment.

  2015cites this paper
• Sex and gender impact lyme disease immunopathology, diagnosis and treatment

  2015cites this paper
• Posttreatment Lyme disease syndrome.

  2015cites this paper
• Lyme disease/borreliosis as a systemic disease.

  2015cites this paper
• Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about their aetiology.

  2015cites this paper
• Correlation of Culture Positivity, PCR Positivity, and Burden of Borrelia burgdorferi Sensu Lato in Skin Samples of Erythema Migrans Patients with Clinical Findings

  2015cites this paper
• Incidence and Patterns of Extended-Course Antibiotic Therapy in Patients Evaluated for Lyme Disease.

  2015cites this paper
• Editorial commentary: what constitutes appropriate treatment of post-Lyme disease symptoms and other pain and fatigue syndromes?

  2015cites this paper
• Infection and Autoimmunity in Antibiotic-Refractory Lyme Arthritis

  2015cites this paper